Psyence Group Invited as First Psychedelic Company to present at the 15th-Annual Global Wellness Summit
November 26, 2021 11:00 ET
|
Psyence Group Inc.
TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company with a focus on natural psychedelics in...
Psyence Group Announces Commencement of Trading on OTCQB and DTC Eligibility of Common Shares in the United States Under the Ticker “PSYGF”
October 13, 2021 07:30 ET
|
Psyence Group Inc.
TORONTO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics...
Psyence Group Jamaica Chief Medical Officer Dr. Dingle Spence to Headline Two Conferences on Psychedelics
October 12, 2021 10:37 ET
|
Psyence Group Inc.
TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental...
Psyence Group and Pure Extracts Finalize “Pure Psyence,” A Joint Venture for the Development of Psychedelic Medicinal Mushroom Extracts
September 28, 2021 07:30 ET
|
Psyence Group Inc.
A Canadian partnership with international ties to advance the field of psychedelic medicine globally with standardized extractsA leader in naturally-derived psilocybin for extraction, production of...
Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” Products
August 18, 2021 07:30 ET
|
Psyence Group Inc.
TORONTO and CAPE TOWN, South Africa, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural...
Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical Trial
July 07, 2021 07:30 ET
|
Psyence Group Inc.
TORONTO, July 07, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental...
Psyence Group Announces Appointment of New Chief Executive Officer
June 28, 2021 07:30 ET
|
Psyence Group Inc.
TORONTO, June 28, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental...
Psyence Group Announces Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development
June 17, 2021 07:30 ET
|
Psyence Group Inc.
TORONTO, June 17, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (“Psyence” or the “Company”) (PSYG:CSE), a public life science biotechnology company pioneering the use of natural psychedelics, is...
The Psyence Group Announces its Formal Entry into Jamaica with the Incorporation of its Wholly Owned Subsidiary, Psyence Jamaica Limited
June 08, 2021 07:30 ET
|
Psyence Group Inc.
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (“Psyence” or the “Company”) (PSYG:CSE), a Canadian public biotechnology company with a global presence, is pleased to announce the...
Psyence Group Corporate Update
May 27, 2021 07:30 ET
|
Psyence Group Inc.
TORONTO, May 27, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”) is pleased to provide the following corporate update on its three clear paths to revenue and...